Get startedLog in
    Picture of HLS Therapeutics logo

    HLS — HLS Therapeutics News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareBalancedSmall CapSuper Stock
    All News

    Brief: Hls Therapeutics Announces Q3 Fiscal 2022 Financial Results

    Picture of HLS Therapeutics logoHLS Therapeutics
    10/11/2022 12:46
    Nov 10 (Reuters) - Hls Therapeutics Inc  HLS.TO :
    * Q3 LOSS PER SHARE $0.14
    * HLS THERAPEUTICS ANNOUNCES Q3 FISCAL 2022 FINANCIAL
RESULTS AND
RENEWAL OF NORMAL COURSE ISSUER BID
    * QTRLY REVENUE WAS $15.7 MILLION COMPARED TO $15.1 MILLION
IN Q3
2021
    * Q3 REVENUE VIEW $16.6 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nCNW8zs6xa 
Further company coverage:  HLS.TO 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on HLS Therapeutics

    See all news